세계의 IoT 의료기기 시장 : 제품별, 유형별, 접속 기술별, 최종 사용자별, 지역별 예측(-2030년)

The global IoT medical devices market is projected to reach USD 154.74 billion by 2030, up from USD 65.08 billion in 2025, reflecting a CAGR of 18.9% during this period. The market is growing rapidly due to an increasing demand for continuous and real-time patient monitoring, particularly with the wider adoption of telehealth. Recent innovations in low-energy sensors, 5G networks, and edge computing have made it possible to efficiently collect and transmit data from wearable and implantable devices to healthcare systems. These advancements enable more proactive and decentralized care, leading to fewer hospital readmissions. Furthermore, the rising incidence of chronic conditions and an aging global population are driving the greater use of these technologies in both home and clinical settings.

However, the market faces challenges, such as the complexity of integrating with legacy health IT infrastructure, compliance with data privacy regulations like HIPAA and GDPR, and the need to maintain strong cybersecurity to protect patient information in an increasingly connected ecosystem.

"The hospitals & clinics segment, under the IoT medical devices market, is expected to register the fastest growth during the forecast period."

In 2024, the hospitals & clinics segment emerged as the leading end user segment in the IoT medical devices market, a position it is expected to maintain in the coming years. This leadership is primarily due to the increasing demand for advanced diagnostic, monitoring, and treatment tools within healthcare facilities. By adopting IoT-enabled technologies, these institutions can enhance patient outcomes through real-time data monitoring, remote care capabilities, and streamlined clinical operations. The ability to continuously track patient vital signs and chronic health conditions allows for quicker interventions and more effective care delivery. Additionally, the integration of IoT with electronic health records (EHRs) and clinical decision-making platforms improves data accuracy and fosters better coordination among care teams. Key factors driving this trend include the push for higher efficiency, rising patient volumes, and the necessity to meet stringent regulatory and quality standards. As a result, hospitals and clinics are making substantial investments in IoT technologies to improve performance, ensure compliance, and provide more responsive, personalized patient care.

"Bluetooth-enabled IoT technology is projected to dominate the IoT medical devices market during the forecast period."

Bluetooth-enabled IoT technology is rapidly emerging as the fastest-growing connectivity option in the IoT medical devices market. This growth is primarily driven by its energy efficiency, easy integration, and wide compatibility with smartphones, tablets, and wearable healthcare devices. As more healthcare organizations adopt connected solutions for continuous monitoring and patient interaction, Bluetooth has become a reliable and cost-effective method for short-range data exchange. It plays a vital role in devices such as fitness trackers, mobile diagnostic equipment, and home health monitoring tools, where low power consumption and consistent data transfer are crucial.

"Asia Pacific is expected to register fastest market growth during the forecast period."

The Asia Pacific region is expected to experience the fastest growth in the IoT medical devices market during the forecast period. This growth is primarily driven by the rapid adoption of digital healthcare technologies, including IoT and artificial intelligence. Government initiatives aimed at improving healthcare infrastructure, combined with significant investments in smart hospitals and digital health platforms, are leading to the increased deployment of connected medical devices. Additionally, the rising demand for remote monitoring solutions, fueled by a growing elderly population and an increase in chronic health conditions, is further propelling this trend. Furthermore, enhanced telecommunications networks and supportive regulatory frameworks for digital health services are facilitating the implementation of IoT-based solutions. As a result, Asia-Pacific is emerging as a key player in the global expansion of the IoT medical device industry.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation - C-level: 42%, Director-level: 31%, and Others: 27%
• By Region - North America: 32%, Asia Pacific: 32%, Europe: 26%, Latin America: 5% and Middle East & Africa: 5%

Key Players in the IoT Medical Devices Market

The key players functioning in the IoT medical devices market include Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), Boston Scientific Corporation (US), OMRON Corporation (Japan), Baxter International Inc. (US), BIOTRONIK (Germany), Johnson & Johnson Private Limited (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Honeywell International Inc. (US), AliveCor, Inc. (US), Dragerwerk AG & Co. KGaA (Germany), Nonin (US), AMD Global Telemedicine (US), iHealth Labs Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), i-SENS, Inc. (Korea), Huntleigh Healthcare Limited (UK), ResMed (US), Masimo (US), Infinium Medical (US), ICU Medical, Inc. (US), and Hamilton Medical (Switzerland).

Research Coverage

The report analyzes the IoT medical devices market and aims to estimate the market size and future growth potential of various market segments based on product, type, connectivity technology, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will provide valuable insights for both, established companies and new or smaller firms, helping them understand market trends and dynamics. By doing so, they can increase their market share. Companies that purchase this report can employ one or more of the strategies outlined below to enhance their positions in the market.

This report provides insights on:

• Analysis of key drivers: Drivers (government initiatives to promote digital health), restraints (high deployment cost of connected medical devices), opportunities (low doctor-to-patient ratio in several countries), and challenges (data security issues) are key factors influencing the growth of the IoT medical devices market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the IoT medical devices market
• Market Development: Comprehensive information on the lucrative emerging markets, product, type, connectivity technology, end user, and region
• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the IoT medical devices market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, product offerings, and capabilities of the leading players in the IoT medical devices market like Medtronic (Ireland), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Abbott (US), and Boston Scientific Corporation (US)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DESIGN
  • 2.1.1 RESEARCH DATA
  • 2.1.2 SECONDARY SOURCES
    • 2.1.2.1 Key data from secondary sources
  • 2.1.3 PRIMARY SOURCES
    • 2.1.3.1 Key data from primary sources
    • 2.1.3.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 LIMITATIONS
• 2.5 MARKET SHARE ANALYSIS
• 2.6 ASSUMPTIONS
• 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 IOT MEDICAL DEVICES MARKET OVERVIEW
• 4.2 ASIA PACIFIC: IOT MEDICAL DEVICES MARKET, BY TYPE AND COUNTRY
• 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES IN IOT MEDICAL DEVICES MARKET
• 4.4 REGIONAL MIX: IOT MEDICAL DEVICES MARKET
• 4.5 IOT MEDICAL DEVICES MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Government initiatives to promote digital health
    • 5.2.1.2 Growing need for cost-containment in healthcare delivery
    • 5.2.1.3 Rising focus on patient engagement and patient-centric healthcare
    • 5.2.1.4 Evolution of high-speed networking technologies
    • 5.2.1.5 Growing focus on patient safety
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High deployment costs of connected medical devices
    • 5.2.2.2 Lack of skilled IT personnel across healthcare organizations
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Low doctor-to-patient ratio in several countries
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Data security issues
    • 5.2.4.2 Data management and interoperability concerns
• 5.3 INDUSTRY INSIGHTS
  • 5.3.1 INCREASING NUMBER OF PRODUCT LAUNCHES
  • 5.3.2 GROWING INTEGRATION OF CLOUD PLATFORMS AND SAAS IN HEALTHCARE ECOSYSTEM
  • 5.3.3 INCREASING NUMBER OF COLLABORATIONS TO DRIVE INNOVATION
• 5.4 TECHNOLOGY ANALYSIS
• 5.5 PORTER'S FIVE FORCES ANALYSIS
  • 5.5.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5.2 BARGAINING POWER OF SUPPLIERS
  • 5.5.3 BARGAINING POWER OF BUYERS
  • 5.5.4 THREAT OF NEW ENTRANTS
  • 5.5.5 THREAT OF SUBSTITUTES
• 5.6 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.6.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.6.2 BUYING CRITERIA
• 5.7 REGULATORY ANALYSIS
  • 5.7.1 NORTH AMERICA
    • 5.7.1.1 US
    • 5.7.1.2 Canada
  • 5.7.2 EUROPE
  • 5.7.3 ASIA PACIFIC
    • 5.7.3.1 Japan
    • 5.7.3.2 China
    • 5.7.3.3 India
• 5.8 VALUE CHAIN ANALYSIS
• 5.9 ECOSYSTEM ANALYSIS
• 5.10 PRICING ANALYSIS
• 5.11 PATENT ANALYSIS
  • 5.11.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.11.2 LIST OF MAJOR PATENTS
• 5.12 CASE STUDY ANALYSIS
  • 5.12.1 CASE STUDY 1: ADVANCING WOUND MEASUREMENT ACCURACY IN HEALTHCARE WITH IOT TECHNOLOGY
  • 5.12.2 CASE STUDY 2: EMPOWERING PATIENT-CONTROLLED PAIN MEDICATION ADMINISTRATION WITH IOT TECHNOLOGY
  • 5.12.3 CASE STUDY 3: IMPROVING MATERNAL AND FETAL CARE WITH IOT-DRIVEN MONITORING SOLUTIONS
• 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.15 IMPACT OF 2025 US TARIFFS-IOT MEDICAL DEVICES MARKET
  • 5.15.1 INTRODUCTION
  • 5.15.2 KEY TARIFF RATES
  • 5.15.3 PRICE IMPACT ANALYSIS
  • 5.15.4 IMPACT ON COUNTRY/REGION
    • 5.15.4.1 US
    • 5.15.4.2 Europe
    • 5.15.4.3 Asia Pacific
  • 5.15.5 IMPACT ON END-USE INDUSTRIES

6 IOT MEDICAL DEVICES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 VITAL SIGNS MONITORING DEVICES
  • 6.2.1 BLOOD GLUCOSE MONITORS
    • 6.2.1.1 Preference for continuous glucose monitoring to drive market
  • 6.2.2 ECG/HEART RATE MONITORS
    • 6.2.2.1 Rising incidence of CVD to drive market growth
  • 6.2.3 BLOOD PRESSURE MONITORS
    • 6.2.3.1 Growing prevalence of hypertension and obesity to fuel market
  • 6.2.4 MULTIPARAMETER MONITORS
    • 6.2.4.1 Rising preference for home care to drive demand
  • 6.2.5 OXIMETERS
    • 6.2.5.1 Increasing focus on self-monitoring to drive market
• 6.3 IMAGING SYSTEMS
  • 6.3.1 NEED TO TRANSMIT DATA FOR REMOTE VIEWING TO SUPPORT MARKET GROWTH
• 6.4 IMPLANTABLE CARDIAC DEVICES
  • 6.4.1 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    • 6.4.1.1 Growing geriatric population to boost demand
  • 6.4.2 PACEMAKERS
    • 6.4.2.1 Rising number of cardiac patients to drive demand
  • 6.4.3 IMPLANTABLE CARDIAC MONITORS
    • 6.4.3.1 Ease of remote monitoring to drive demand
• 6.5 PATIENT MONITORS
  • 6.5.1 GROWING ADOPTION TO BOOST MARKET
• 6.6 RESPIRATORY DEVICES
  • 6.6.1 RISING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE DEMAND
• 6.7 INFUSION PUMPS
  • 6.7.1 RISK OF SECURITY BREACHES TO IMPACT MARKET GROWTH
• 6.8 FETAL MONITORING DEVICES
  • 6.8.1 GROWING EMPHASIS ON FETAL HEALTH TO DRIVE MARKET GROWTH
• 6.9 NEUROLOGICAL DEVICES
  • 6.9.1 TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET
• 6.10 VENTILATORS
  • 6.10.1 HIGH DEMAND FOR INTENSIVE CARE TO DRIVE MARKET GROWTH
• 6.11 ANESTHESIA MACHINES
  • 6.11.1 INCREASING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
• 6.12 HEARING DEVICES
  • 6.12.1 RISING ADOPTION OF ADVANCED AIDS TO BOOST MARKET
• 6.13 OTHER IOT MEDICAL DEVICES

7 IOT MEDICAL DEVICES MARKET, BY TYPE

• 7.1 INTRODUCTION
• 7.2 STATIONARY DEVICES
  • 7.2.1 IMPROVED DATA ACCESSIBILITY TO DRIVE DEMAND
• 7.3 IMPLANTABLE DEVICES
  • 7.3.1 INCREASING INCIDENCE OF CVD AND NEUROLOGICAL DISEASES TO DRIVE DEMAND
• 7.4 WEARABLE DEVICES
  • 7.4.1 RISING USE IN HOME CARE SETTINGS TO PROPEL MARKET
• 7.5 OTHER DEVICE TYPES

8 IOT MEDICAL DEVICES MARKET, BY CONNECTIVITY TECHNOLOGY

• 8.1 INTRODUCTION
• 8.2 WI-FI
  • 8.2.1 ABILITY TO PROVIDE GREATER FLEXIBILITY TO CAREGIVERS TO SUPPORT MARKET GROWTH
• 8.3 BLUETOOTH
  • 8.3.1 SEAMLESS CONNECTION BETWEEN WIRELESS DEVICES TO FOSTER ADOPTION
• 8.4 ZIGBEE
  • 8.4.1 SECURITY CONCERNS TO LIMIT ADOPTION
• 8.5 OTHER CONNECTIVITY TECHNOLOGIES

9 IOT MEDICAL DEVICES MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS & CLINICS
  • 9.2.1 NEED TO REDUCE HEALTHCARE COSTS TO DRIVE MARKET
• 9.3 NURSING HOMES, ASSISTED LIVING FACILITIES, LONG-TERM CARE CENTERS, AND HOME CARE SETTINGS
  • 9.3.1 INCREASING GERIATRIC POPULATION TO CONTRIBUTE TO SEGMENT GROWTH
• 9.4 OTHER END USERS

10 IOT MEDICAL DEVICES MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 High adoption of connected devices to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Government investments in health-related technologies to boost market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Government initiatives to boost market
  • 10.3.3 UK
    • 10.3.3.1 High penetration of wearables to drive market
  • 10.3.4 FRANCE
    • 10.3.4.1 Government support for e-Health to drive market
  • 10.3.5 ITALY
    • 10.3.5.1 Widespread use of mobile devices to drive market
  • 10.3.6 SPAIN
    • 10.3.6.1 Growing geriatric population to propel demand
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 High burden of chronic disorders to drive demand
  • 10.4.3 JAPAN
    • 10.4.3.1 Demand from large geriatric population to boost market
  • 10.4.4 INDIA
    • 10.4.4.1 Growing adoption of telemedicine to boost market
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Increasing government initiatives to drive market
  • 10.5.3 MEXICO
    • 10.5.3.1 Focus on digitalization of healthcare to support market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 INTRODUCTION
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN IOT MEDICAL DEVICES MARKET
• 11.3 REVENUE ANALYSIS, 2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Type footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startups/SMEs
• 11.7 VALUATION & FINANCIAL METRICS
  • 11.7.1 FINANCIAL METRICS
  • 11.7.2 COMPANY VALUATION
• 11.8 BRAND/SOFTWARE COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY COMPANIES
  • 12.1.1 MEDTRONIC
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches & approvals
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Other developments
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths/Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses and competitive threats
  • 12.1.2 GE HEALTHCARE
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches & approvals
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths/Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses and competitive threats
  • 12.1.3 KONINKLIJKE PHILIPS N.V.
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Product launches & enhancements
      • 12.1.3.3.2 Deals
      • 12.1.3.3.3 Other developments
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths/Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses and competitive threats
  • 12.1.4 ABBOTT
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Product launches & approvals
      • 12.1.4.3.2 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths/Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses and competitive threats
  • 12.1.5 BOSTON SCIENTIFIC CORPORATION
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches, enhancements, and approvals
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths/Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses and competitive threats
  • 12.1.6 OMRON CORPORATION
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product & service launches
      • 12.1.6.3.2 Deals
      • 12.1.6.3.3 Expansions
  • 12.1.7 BAXTER INTERNATIONAL, INC.
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Product launches & approvals
      • 12.1.7.3.2 Deals
  • 12.1.8 BIOTRONIK
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Product launches & enhancements
      • 12.1.8.3.2 Deals
  • 12.1.9 JOHNSON & JOHNSON
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Deals
  • 12.1.10 NIHON KOHDEN CORPORATION
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches & approvals
      • 12.1.10.3.2 Deals
      • 12.1.10.3.3 Expansions
  • 12.1.11 SIEMENS HEALTHINEERS AG
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Product launches
      • 12.1.11.3.2 Deals
  • 12.1.12 HONEYWELL INTERNATIONAL, INC.
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
  • 12.1.13 ALIVECOR, INC.
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
    • 12.1.13.3 Recent developments
      • 12.1.13.3.1 Product & service launches
      • 12.1.13.3.2 Deals
  • 12.1.14 DRAGERWERK AG & CO. KGAA
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
    • 12.1.14.3 Recent developments
      • 12.1.14.3.1 Product launches
      • 12.1.14.3.2 Deals
  • 12.1.15 NONIN
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
    • 12.1.15.3 Recent developments
      • 12.1.15.3.1 Product launches
      • 12.1.15.3.2 Deals
  • 12.1.16 RESMED
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products offered
    • 12.1.16.3 Recent developments
      • 12.1.16.3.1 Product launches
      • 12.1.16.3.2 Deals
      • 12.1.16.3.3 Expansions
      • 12.1.16.3.4 Other developments
  • 12.1.17 MASIMO
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products offered
    • 12.1.17.3 Recent developments
      • 12.1.17.3.1 Product launches & approvals
      • 12.1.17.3.2 Deals
  • 12.1.18 I-SENS, INC.
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Product launches & approvals
      • 12.1.18.3.2 Deals
      • 12.1.18.3.3 Expansions
  • 12.1.19 ICU MEDICAL, INC.
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Product approvals
      • 12.1.19.3.2 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 AMD GLOBAL TELEMEDICINE
  • 12.2.2 IHEALTH LABS
  • 12.2.3 AEROTEL MEDICAL SYSTEMS
  • 12.2.4 HUNTLEIGH HEALTHCARE LIMITED
  • 12.2.5 INFINIUM MEDICAL
  • 12.2.6 HAMILTON MEDICAL

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS